Biotech Values

[DewDiligence]

RVNC—Someone asked me on Twitter why interim phase-2 data in cervical dystonia have been pushed back to 2H16 (rather than 1H16, as guided by RVNC in Jan 2016 in the message I'm replying to).

Answer: RVNC added an unplanned high-dose (450U) cohort to the study (

Above info from $RVNC 1Q16 CC today. CD = cervical dystonia.

— Roy Friedman (@DewDiligence) May 9, 2016

).